Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ERIKA G GONZALEZ

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1427022516
CMS profile
337313
Location
SAN ANTONIO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$9,833.06

114 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $5,600.00 1
Food and Beverage $2,576.86 106
Travel and Lodging $1,599.20 6
Education $57.00 1

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ERIKA G GONZALEZ

NPI 1427022516 · CMS profile ID 337313

Allopathic & Osteopathic Physicians / Allergy & Immunology

SAN ANTONIO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1427022516?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ERIKA G GONZALEZ, NPI 1427022516, CMS profile ID 337313. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1427022516?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). ERIKA G GONZALEZ, NPI 1427022516, CMS profile ID 337313. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1427022516?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
ERIKA G GONZALEZ, NPI 1427022516, CMS profile ID 337313, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1427022516?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

114 matching records · $9,833.06 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 114 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 114.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Genentech USA, Inc. $2.6805/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040360189 CMS
Blueprint Medicines Corporation $13.7105/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051273967 CMS
GENZYME CORPORATION $119.1105/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050039215 CMS
Regeneron Healthcare Solutions, Inc. $26.6705/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999190943 CMS
Octapharma USA, Inc. $20.0005/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042723783 CMS
Amgen Inc. $18.9305/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019905717 CMS
Regeneron Healthcare Solutions, Inc. $23.6905/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999190939 CMS
GENZYME CORPORATION $25.6105/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050039235 CMS
GlaxoSmithKline, LLC. $30.3805/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001544435 CMS
GlaxoSmithKline, LLC. $11.4704/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001545059 CMS
kaleo, Inc. $15.4804/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1013029069 CMS
Novartis Pharmaceuticals Corporation $17.0004/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991986375 CMS
GlaxoSmithKline, LLC. $10.4404/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001544475 CMS
GlaxoSmithKline, LLC. $14.4904/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001542407 CMS
Incyte Corporation $14.2004/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044170743 CMS
GlaxoSmithKline, LLC. $15.8303/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001543859 CMS
Regeneron Healthcare Solutions, Inc. $34.1503/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999190935 CMS
SANOFI-AVENTIS U.S. LLC $21.1003/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050039171 CMS
GENZYME CORPORATION $34.7003/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050039175 CMS
Regeneron Healthcare Solutions, Inc. $28.8303/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999190931 CMS
Regeneron Pharmaceuticals, Inc. $21.3303/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000013051 CMS
SANOFI-AVENTIS U.S. LLC $11.2803/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050039167 CMS
Novartis Pharmaceuticals Corporation $19.3203/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991986371 CMS
SANOFI-AVENTIS U.S. LLC $16.2403/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050039163 CMS
AstraZeneca UK Limited $48.6503/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016984019 CMS
AstraZeneca UK Limited $54.8503/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017022993 CMS
GENZYME CORPORATION $15.0603/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050039179 CMS
Grifols USA, LLC $17.6803/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011873639 CMS
AstraZeneca Pharmaceuticals LP $13.3203/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015344893 CMS
Genentech USA, Inc. $15.6103/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040360161 CMS
Novartis Pharmaceuticals Corporation $16.3803/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991986367 CMS
ALK-Abello, Inc $22.6103/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017126085 CMS
AstraZeneca UK Limited $645.4003/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016997471 CMS
AstraZeneca UK Limited $116.6703/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017018127 CMS
AstraZeneca UK Limited $83.9603/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017019267 CMS
AstraZeneca UK Limited $145.0003/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017026201 CMS
AstraZeneca UK Limited $225.9403/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017061561 CMS
AstraZeneca Pharmaceuticals LP $18.2003/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016268423 CMS
AstraZeneca Pharmaceuticals LP $36.3602/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015799731 CMS
GENZYME CORPORATION $52.0702/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050039127 CMS
GlaxoSmithKline, LLC. $57.0002/25/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061464697 CMS
GENZYME CORPORATION $34.1902/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050039145 CMS
Genentech USA, Inc. $8.1302/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040360165 CMS
Novartis Pharmaceuticals Corporation $43.0902/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991986351 CMS
kaleo, Inc. $17.4202/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1013029061 CMS
AstraZeneca Pharmaceuticals LP $14.0002/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014531247 CMS
GlaxoSmithKline, LLC. $4.1202/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001543001 CMS
GlaxoSmithKline, LLC. $11.0802/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1001545163 CMS
Regeneron Healthcare Solutions, Inc. $28.3702/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999190927 CMS
SANOFI-AVENTIS U.S. LLC $27.5202/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050039119 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $9,654.73 49
PY2020 $9,134.60 36
PY2021 $11,046.80 67
PY2022 $8,891.41 112
PY2023 $9,833.06 114
PY2024 $866.32 38
PY2025 $2,182.80 56

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $365,230.57 522
PY2024 Principal investigator $249,852.55 169
PY2023 Principal investigator $219,935.68 171
PY2022 Principal investigator $302,366.57 72
PY2021 Principal investigator $357,558.38 45
PY2020 Principal investigator $396,007.51 42
PY2019 Recipient $1,667.94 5
PY2019 Principal investigator $240,846.48 34

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

522 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $500.00 12/24/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184280236
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $1,000.00 12/24/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184280238
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $1,000.00 12/24/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184280240
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $2,544.72 12/11/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK LLC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244045884
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $1,365.00 11/26/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK LLC
AIM4: NEXT STEP - ASTHMA UNCONTROLLED WITH ICS IN MEDIUM DOSE (GINA 4): NEXT STEP; EFFICACY OF DUPILUMAB ADDED TO MEDIUM DOSE ICS/LABA IN COMPARISON TO ICS DOSE ESCALATION TO HIGH DOSE ICS/LABA IN PATIENTS WITH UNCONTROLLED ASTHMA No dispute reported 06/30/2026 1184265429
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $150.00 11/26/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK LLC
AIM4: NEXT STEP - ASTHMA UNCONTROLLED WITH ICS IN MEDIUM DOSE (GINA 4): NEXT STEP; EFFICACY OF DUPILUMAB ADDED TO MEDIUM DOSE ICS/LABA IN COMPARISON TO ICS DOSE ESCALATION TO HIGH DOSE ICS/LABA IN PATIENTS WITH UNCONTROLLED ASTHMA No dispute reported 06/30/2026 1184265431
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $150.00 11/26/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK LLC
AIM4: NEXT STEP - ASTHMA UNCONTROLLED WITH ICS IN MEDIUM DOSE (GINA 4): NEXT STEP; EFFICACY OF DUPILUMAB ADDED TO MEDIUM DOSE ICS/LABA IN COMPARISON TO ICS DOSE ESCALATION TO HIGH DOSE ICS/LABA IN PATIENTS WITH UNCONTROLLED ASTHMA No dispute reported 06/30/2026 1184265433
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $150.00 11/26/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK LLC
AIM4: NEXT STEP - ASTHMA UNCONTROLLED WITH ICS IN MEDIUM DOSE (GINA 4): NEXT STEP; EFFICACY OF DUPILUMAB ADDED TO MEDIUM DOSE ICS/LABA IN COMPARISON TO ICS DOSE ESCALATION TO HIGH DOSE ICS/LABA IN PATIENTS WITH UNCONTROLLED ASTHMA No dispute reported 06/30/2026 1184265435
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $13,645.44 11/20/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK LLC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244046102
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $3,000.00 11/13/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK LLC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244046100
Principal investigator 1 Novartis Pharmaceuticals Corporation $315.71 11/10/2025 Non-covered Recipient Entity
SYLVANA RESEARCH ASSOCIATES
A 52-week multi-center, randomized, double-blind, placebo controlled, basket study with an open-label extension to investigate the efficacy, safety, and tolerability of remibrutinib (LOU064) in Chronic Inducible Urticaria (CINDU) in adults inadequately co No dispute reported 06/30/2026 1190298719
Principal investigator 1 Amgen Inc. $3,500.00 10/24/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma No dispute reported 06/30/2026 1246648661
Principal investigator 1 AstraZeneca UK Limited $9,000.00 10/16/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
Multicentre,Randomised,Double blind,Parallel Group,Placebo controlled,Time to first Asthma Exacerbation Phase tree Efficacy and Safety Study of Benralizumab in Paediatric Patients with Severe Eosinophilic Asthma Dominika No dispute reported 06/30/2026 1185549261
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $1,000.00 10/09/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK LLC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244046096
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $5,456.00 10/09/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK LLC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244046098
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $754.65 10/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184246560
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $754.65 10/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184246562
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $3,964.86 09/25/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK LLC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244046094
Principal investigator 1 AstraZeneca Pharmaceuticals LP $7,200.00 09/19/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK
A Phase II, Randomized, Double-blind, Single-dose, Placebo-controlled, 3-Period, 3-Treatment, Crossover, Multicenter Study to Compare the Bronchodilatory Effect and Safety of PT007 AS MDI to Placebo MDI and Open-Label Ventolin Evohaler in Adult Participants with Asthma MITCHELL No dispute reported 06/30/2026 1185549263
Principal investigator 1 AstraZeneca UK Limited $26,500.00 09/12/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
BRISOTE A Multicentre Randomised DoubleBlind Parallel Group ActiveControlled Phase 3b Study to Evaluate the Efficacy and Safety of Benralizumab 30 mg SC in Eosinophilic Asthma Patients Uncontrolled on Medium Dose Inhaled Corticosteroid Plus Long acting 2 Agonist No dispute reported 06/30/2026 1185549259
Principal investigator 1 Optinose US, Inc. $6,500.00 09/05/2025 Non-covered Recipient Entity
Midwest Allergy Sinus Asthma, SC
A 12-Week Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Intranasal Administration of 186 mcg of OPN-375 Twice a Day (BID) in Adolescent Subjects With Chronic Rhinosinusitis Without Nasal Polyps No dispute reported 06/30/2026 1163251989
Principal investigator 1 Novartis Pharmaceuticals Corporation $63,730.60 09/01/2025 Non-covered Recipient Entity
SYLVANA RESEARCH ASSOCIATES
A 52-week multi-center, randomized, double-blind, placebo controlled, basket study with an open-label extension to investigate the efficacy, safety, and tolerability of remibrutinib (LOU064) in Chronic Inducible Urticaria (CINDU) in adults inadequately co No dispute reported 06/30/2026 1190298724
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $9,944.28 08/21/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK LLC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244046092
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $15,946.59 06/24/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK LLC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244046298
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $274.95 06/18/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184207681
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $274.95 06/18/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184207683
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $754.65 06/18/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184207971
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $754.65 06/18/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184207973
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $754.65 06/18/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184207975
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $1,813.06 05/08/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK LLC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244046296
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 05/07/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184193415
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 05/07/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184193417
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 05/07/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184193419
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 05/07/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184193421
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 05/07/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184193423
Principal investigator 1 AstraZeneca Pharmaceuticals LP $37,930.80 05/01/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
a randomized,double blind,multicenter,parallel group,phase IIIb 52 week study evaluating the efficacy and safety of PT027 compared with PT007 administered as needed in participants 12 to under 18 years of age with asthma ACADIA No dispute reported 06/30/2026 1185549257
Principal investigator 1 AstraZeneca UK Limited $34,921.30 04/28/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK
a randomized,double blind,multicenter,parallel group,phase IIIb 52 week study evaluating the efficacy and safety of PT027 compared with PT007 administered as needed in participants 12 to under 18 years of age with asthma ACADIA No dispute reported 06/30/2026 1185549253
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $468.39 04/28/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184190509
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $468.39 04/28/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184190511
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $468.39 04/28/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184190513
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $468.39 04/28/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184190515
Principal investigator 1 GlaxoSmithKline, LLC. $796.05 04/02/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONT No dispute reported 06/30/2026 1192145431
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $204.60 03/03/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK LLC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244046002
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $754.65 02/27/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184155826
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $274.95 02/27/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184155828
Principal investigator 1 GlaxoSmithKline, LLC. $9,927.71 02/26/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONT No dispute reported 06/30/2026 1192142818
Principal investigator 1 Amgen Inc. $1,869.52 02/25/2025 Non-covered Recipient Entity
SOUTH TEXAS ALLERGY AND ASTHMA MEDICAL PROFESSIONALS
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Assess the Efficacy and Safety of Rocatinlimab in Adult Subjects With Moderate-to-severe Asthma No dispute reported 06/30/2026 1246648379
Principal investigator 1 AstraZeneca Pharmaceuticals LP $5,075.81 02/24/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
The CHRONICLE Study is a multi center,non interventional,prospective cohort study of adults with severe asthma who do not achieve control with high-dose ICS therapy with additional controllers and or require systemic corticosteroid or monoclonal antibod No dispute reported 06/30/2026 1185549265
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $10,480.54 02/13/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK LLC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244046294
Principal investigator 1 SANOFI US SERVICES INC. $17,200.00 02/12/2025 Non-covered Recipient Entity
Staamp Research Llc
ACT - POC clinical study - IL13 x TSLP Nanobody VHH - lunsekimig No dispute reported 06/30/2026 1226103666
Principal investigator 1 GlaxoSmithKline, LLC. $1,723.20 02/07/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONT No dispute reported 06/30/2026 1192142811
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $80.00 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151863
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $80.00 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151865
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $80.00 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151869
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $80.00 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151871
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $80.00 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151873
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $80.00 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151875
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $80.00 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151877
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $80.00 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151879
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $80.00 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151881
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $80.00 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151883
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $80.00 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151885
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $80.00 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151887
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $80.00 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151891
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $80.00 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151893
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $80.00 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151895
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $80.00 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151897
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $165.10 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151899
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $45.50 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151901
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.70 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151903
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $28.60 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151905
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $35.10 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151907
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $33.80 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151909
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.70 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151913
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $62.40 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151915
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $165.10 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151917
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151919
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $33.80 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151921
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $165.10 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151923
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.70 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151925
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $165.10 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151927
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $165.10 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151929
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.70 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151931
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $35.10 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151935
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $50.70 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151937
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.70 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151939
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.70 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151941
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $45.50 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151943
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $26.00 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151945
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151947
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.70 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151949
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $35.10 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151951
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $28.60 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151953
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $165.10 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151957
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $35.10 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151959
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $28.60 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151961
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.70 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151963
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $45.50 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151965
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $165.10 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151967
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $165.10 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151969
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $165.10 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151971
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.70 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151973
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $35.10 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151975
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $28.60 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151979
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $50.70 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151981
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.70 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151983
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $45.50 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151985
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $50.70 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151987
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $33.80 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151989
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.70 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151991
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $28.60 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151993
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $35.10 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151995
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $45.50 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184151997
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.70 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184152001
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.70 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184152003
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $45.50 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184152005
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.70 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184152007
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $62.40 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184152009
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184152011
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $50.70 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184152013
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $28.60 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184152015
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $35.10 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184152017
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $37.70 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184152019
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $165.10 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184152023
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $33.80 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184152025
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $4,338.10 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184152027
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $62.40 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184152029
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184152031
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $754.65 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184152033
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $754.65 02/05/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
ASSESSING LONG-TERM OUTCOMES OF DUPIXENT TREATMENT IN PATIENTS WITH CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS (AROMA) No dispute reported 06/30/2026 1184152035
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $2,535.00 01/20/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK LLC
AIM4: NEXT STEP - ASTHMA UNCONTROLLED WITH ICS IN MEDIUM DOSE (GINA 4): NEXT STEP; EFFICACY OF DUPILUMAB ADDED TO MEDIUM DOSE ICS/LABA IN COMPARISON TO ICS DOSE ESCALATION TO HIGH DOSE ICS/LABA IN PATIENTS WITH UNCONTROLLED ASTHMA No dispute reported 06/30/2026 1184148874
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $9,500.00 01/20/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK LLC
AIM4: NEXT STEP - ASTHMA UNCONTROLLED WITH ICS IN MEDIUM DOSE (GINA 4): NEXT STEP; EFFICACY OF DUPILUMAB ADDED TO MEDIUM DOSE ICS/LABA IN COMPARISON TO ICS DOSE ESCALATION TO HIGH DOSE ICS/LABA IN PATIENTS WITH UNCONTROLLED ASTHMA No dispute reported 06/30/2026 1184148876
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $974.00 01/20/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK LLC
AIM4: NEXT STEP - ASTHMA UNCONTROLLED WITH ICS IN MEDIUM DOSE (GINA 4): NEXT STEP; EFFICACY OF DUPILUMAB ADDED TO MEDIUM DOSE ICS/LABA IN COMPARISON TO ICS DOSE ESCALATION TO HIGH DOSE ICS/LABA IN PATIENTS WITH UNCONTROLLED ASTHMA No dispute reported 06/30/2026 1184148878
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $68.20 01/13/2025 Non-covered Recipient Entity
CRN CLINICAL RESEARCH NETWORK LLC
A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma No dispute reported 06/30/2026 1244046000
Principal investigator 1 AstraZeneca Pharmaceuticals LP $14,130.89 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
A Randomized Double Blind Double Dummy Parallel Group Multicenter 24 to 52 Week Variable Length Study to Assess the Efficacy and Safety of Budesonide Glycopyrronium and Formoterol Fumarate Metered Dose Inhaler No dispute reported 06/30/2026 1185549255
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144852
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144854
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144856
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144858
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144860
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144862
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144864
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144866
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144868
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144870
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144872
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144874
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144876
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144878
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144880
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144882
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144884
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144886
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144888
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144890
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144892
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144894
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144896
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144898
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144900
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144902
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144904
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144906
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144908
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144910
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144912
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144914
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144916
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144918
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144920
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144922
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144924
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144926
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144928
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144930
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144932
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144934
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144936
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144938
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144940
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144942
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144944
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144946
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144948
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144950
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144952
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144954
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144956
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144958
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144960
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144962
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144964
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144966
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144968
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144970
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144972
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144974
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144976
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144978
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144980
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144982
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144984
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144986
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144988
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144990
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144992
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144994
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144996
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184144998
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145000
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145002
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145004
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145006
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145008
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145010
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145012
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145014
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145016
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145018
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145020
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145022
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145024
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145026
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145028
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145030
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145032
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145034
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145036
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145038
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145040
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145042
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145044
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145046
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145048
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145050
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145052
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145054
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145056
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145058
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145060
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145062
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145064
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145066
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145068
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145070
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145072
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145074
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145076
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145078
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145080
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145082
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145084
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145086
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145088
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145090
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145092
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145094
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145096
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145098
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145100
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145102
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145104
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145106
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145108
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145110
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145112
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145114
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145116
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145118
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145120
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145122
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145124
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145126
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145128
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145130
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145132
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145134
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145136
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145138
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145140
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145142
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145144
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145146
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145148
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145150
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145152
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145154
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145156
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145158
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145160
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145162
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145164
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145166
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145168
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145170
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145172
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145174
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145176
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145178
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145180
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145182
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145184
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145186
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145188
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145190
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145192
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145194
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145196
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145198
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145200
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145202
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145204
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145206
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145208
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145210
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145212
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145214
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145216
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145218
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145220
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145222
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145224
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145226
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145228
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145230
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145232
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145234
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145236
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145238
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145240
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145242
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145244
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145246
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145248
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145250
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145252
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145254
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145256
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145258
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145260
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145262
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145264
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145266
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145268
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145270
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145272
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145274
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145276
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145278
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145280
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145282
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145284
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145286
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145288
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145290
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145292
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145294
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145296
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145298
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145300
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145302
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145304
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145306
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145308
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145310
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145312
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145314
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145316
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145318
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145320
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145322
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145324
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145326
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145328
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145330
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145332
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145334
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145336
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145338
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145340
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145342
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145344
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145346
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145348
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145350
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145352
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145354
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145356
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145358
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145360
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $26.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145362
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145364
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145366
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145368
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145370
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145372
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145374
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145376
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145378
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145380
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145382
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145384
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145386
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145388
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145390
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145392
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145394
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145396
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145398
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145400
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145402
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145404
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145406
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145408
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145410
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145412
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145414
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145416
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145418
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145420
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145422
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145424
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145426
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145428
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145430
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145432
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145434
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145436
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145438
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145440
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145442
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145444
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145446
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145448
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145450
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145452
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145454
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145456
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145458
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145460
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145462
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145464
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145466
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145468
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145470
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145472
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145474
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145476
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145478
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145480
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145482
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145484
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145486
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145488
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145490
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145492
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145494
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145496
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145498
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145500
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145502
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145504
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145506
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145508
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145510
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145512
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145514
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145516
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145518
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145520
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145522
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145524
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145526
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145528
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145530
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145532
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145534
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145536
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145538
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145540
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145542
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145544
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145546
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145548
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145550
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145552
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145554
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145556
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145558
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145560
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145562
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145564
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145566
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145568
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145570
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145572
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145574
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145576
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145578
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145580
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145582
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145584
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145586
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145588
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145590
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145592
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145594
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145596
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145598
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145600
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145602
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145604
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145606
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145608
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145610
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145612
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $27.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145614
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $20.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145616
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $25.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145618
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $14.00 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145620
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $32.50 01/03/2025 Non-covered Recipient Entity
STAAMP RESEARCH LLC
REGISTRY OF ASTHMA PATIENTS INITIATING DUPIXENT (RAPID) No dispute reported 06/30/2026 1184145622
Principal investigator 1 Novartis Pharmaceuticals Corporation $12,361.98 01/01/2025 Non-covered Recipient Entity
SYLVANA RESEARCH ASSOCIATES
A 52-week multi-center, randomized, double-blind, placebo controlled, basket study with an open-label extension to investigate the efficacy, safety, and tolerability of remibrutinib (LOU064) in Chronic Inducible Urticaria (CINDU) in adults inadequately co No dispute reported 06/30/2026 1190298727